lung disease | GenomeWeb

lung disease

This Week in PNAS

In PNAS this week: AKT1 mutations in pulmonary sclerosing hemangioma, genomic study of hyper-virulence in Campylobacter jejuni, and more.

Found the Talent

This year's winners of the Intel Talent Search developed software to help in drug development, a smartphone-based tool to detect lung disease, and more.

The center has already sequenced and analyzed 1,500 human genomes for the TOPMed program and will expand this effort with the new funding.

This Week in Nature

In Nature this week: genomic analysis of 200 bird species, and more.

The group hopes to find biomarkers as a first step toward identifying or developing targeted therapeutics to avoid serious and life threatening outcomes of early lung disease in these newborns.

Data for tens of thousands of UK Biobank participants revealed an overlapping set of variants involved in airflow obstruction in heavy and never smokers. 

Researchers now have access to 300 pluripotent stem cell lines to study disease.

NEW YORK (GenomeWeb) – Children's Hospital Colorado and SomaLogic today announced a collaboration aimed at the discovery of protein biomarkers for diagnosing and managing childhood diseases.

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure (PROOF) and MRM Proteomics announced today that they will partner on proteomic-based diagnostic tests for patients with chronic organ diseases.

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure, or PROOF Centre, and IO Informatics today announced a deal to develop a web-based software application addressing chronic heart, lung, and kidney disease.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.